AgingResearch.NewsJoin free

Amyloid PET pathology burden

There is 1 paper on amyloid PET pathology burden in aging research: 1 observational study in people.

Biomarker

1 paper studies it1 finding

See all 1 papers on amyloid PET pathology burden

“Higher baseline p-tau217 is associated with greater future amyloid positron emission tomography (PET) pathology burden.”
Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's diseaseAlzheimer's & dementia : the journal of the Alzheimer's Association2022doi:10.1002/alz.12906
  • Humans1

Associations

1

Plasma P-TAU217

upin humans1

1 study

  1. Plasma P-TAU217 predicts amyloid PET pathology burden in humans (Non-demented presenilin-1 E280A carriers and non-carrier family members).

    “Higher baseline p-tau217 is associated with greater future amyloid positron emission tomography (PET) pathology burden.”

    HumansNon-demented presenilin-1 E280A carriers and non-carrier family membersbrain7.61 years

    Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Plasma P-TAU217

Latest

Related